Skip to content
healthcare.dev
Get a free key

BRYNOVIN

NDC 24338-017, Sitagliptin Hydrochloride Oral, solution, from Azurity Pharmaceuticals, Inc..

Product NDC
24338-017
Status
Listed
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219122
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24338-017 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SITAGLIPTIN25 mg/mL

Pharmacologic classes

Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
24338-017-01243380017011 BOTTLE in 1 CARTON (24338-017-01) / 120 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9468a2f3-3ebe-40bd-a3b4-d78d9eb47e04

Use it

Look up 24338-017 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24338-017 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24338-017. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.